pubmed· e01.org

PubMed · PMID 30871237

Epilepsy Disease and Nose-to-Brain Delivery of Polymeric Nanoparticles: An Overview.

PMID 30871237Journal PharmaceuticsYear 2019Authors 3DOI 10.3390/pharmaceutics11030118

  • Source PubMed
  • Journal Pharmaceutics
  • Year 2019
  • Authors Teresa Musumeci; Angela Bonaccorso; Giovanni Puglisi
  • Licence NLM/PubMed terms

Abstract

Epilepsy is the fourth most common global neurological problem, which can be considered a spectrum disorder because of its various causes, seizure types, its ability to vary in severity and the impact from person to person, as well as its range of co-existing conditions. The approaches to drug therapy of epilepsy are directed at the control of symptoms by chronic administration of antiepileptic drugs (AEDs). These AEDs are administered orally or intravenously but alternative routes of administration are needed to overcome some important limits.

Intranasal (IN) administration represents an attractive route because it is possible to reach the brain bypassing the blood brain barrier while the drug avoids first-pass metabolism. It is possible to obtain an increase in patient compliance for the easy and non-invasive route of administration. This route, however, has some drawbacks such as mucociliary clearance and the small volume that can be administered, in fact, only drugs that are efficacious at low doses can be considered.

The drug also needs excellent aqueous solubility or must be able to be formulated using solubilizing agents. The use of nanomedicine formulations able to encapsulate active molecules represents a good strategy to overcome several limitations of this route and of conventional drugs. The aim of this review is to discuss the innovative application of nanomedicine for epilepsy treatment using nose-to-brain delivery with particular attention focused on polymeric nanoparticles to load drugs.

Record details

PMID30871237
DOI10.3390/pharmaceutics11030118
JournalPharmaceutics
Year2019
AuthorsTeresa Musumeci; Angela Bonaccorso; Giovanni Puglisi
MeSHnot stated

Source record

Open the PubMed record. This page reproduces the abstract and citation fields held in the local baseline; it does not rehost the article.

Source
PubMed / NLM
PMID
30871237
Rendered
2026-11-20
Completeness
Abstract and citation fields only; full text is not rehosted.